Maybe the medical industry doesn't want to lose any market share to MSB, so are going to stall approving restemcell for as long as possible! Also possible is that the old boys club will push the market cap down with shorting and then scoop up the shares at bargain basement prices, or offer to "help" the company out financially with a higher than average interest loan of some kind. Just thinking out aloud!
Maybe the medical industry doesn't want to lose any market share...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.045(4.39%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.07 | $1.02 | $3.933M | 3.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 64483 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 129593 | 10 |
View Market Depth
| Last trade - 14.53pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
0.045 ( 4.81 %) |
||||
| Open | High | Low | Volume | ||
| $1.03 | $1.09 | $1.02 | 607669 | ||
| Last updated 15.09pm 17/05/2024 ? | |||||
| MSB (ASX) Chart |